Skandinaviska Enskilda Banken (SEB)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.46M Buy
67,720
+35,185
+108% +$1.28M 0.01% 549
2025
Q1
$1.18M Buy
+32,535
New +$1.18M 0.01% 621